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This paper presents an electrochemical sensing approach that enables quantitative detection of three major
catecholamine hormones from a mixture by specifically employing a chemically-modified microelectrode array with
α-, β- and γ-cyclodextrin (CD) ‘catchers’ holding unique physical matching (size and shape) as well as chemical
enticing (stereochemistry and surface charge) properties. The developed neurotransmitter sensor has selectively
identified L-tyrosine, dihydroxyphenylalanine (L-DOPA) and dopamine in the absence of ascorbic acid. It exhibited
the relatively linear sensitivities to each neurotransmitter with logarithmically increasing concentrations range of
5μM-10mM, while demonstrating stability up to 6 hours from the fabrication and the average accuracy of 91.2%.
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Neurodegenerative diseases present an increasing burden
for the world health care sector. Currently, 6.5 million
Americans suffer from the neurodegenerative diseases
such as Alzheimer’s disease (5.4 million), Parkinson’s
disease (1 million), amyotrophic lateral sclerosis (30,000),
and Huntington’s disease (15,000) [1-3]. Since the neuro-
degenerative diseases are primarily an age-based disease
with the increasing incidence after age 65 years [4,5] and
the U.S. population continue to age [6], it is estimated
that, by 2040, more than 13.1 million Americans will be
diagnosed with neurodegenerative diseases. Such increase
of the neurodegenerative disease population will cause the
corresponding growth of social costs of treating neuro-
degenerative diseases; thus, developing effective treatments
for the neurodegenerative diseases is an urgent and critical
issue.
For diagnosing and treating the neurodegenerative
diseases, monitoring the concentrations of co-existing
catecholamine neurotransmitters could be critical because
concentrations represent the effectiveness of the derange-
ment of neurotransmitters transferring through a neuron
terminal and was shown to be associated with many neuro-
degenerative diseases. For example, Parkinson’s disease has
high correlation with the lack of dopamine (DA) due to the* Correspondence: hanseup@ece.utah.edu
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in any medium, provided the original work is ploss of dopaminergic neurons in the substantia nigrapars
compacta and degeneration of the nigrostriatal pathway
[7-9]. Although DA concentration is the direct cause of
such diseases, since the biosynthetic pathway of major cat-
echolamine neurotransmitters has been well-understood
(Figure 1), the concentration measurements of these
individual neurotransmitters (L-Tyrosine, L-DOPA and
DA) could provide meaningful insights on the failure mech-
anisms along the pathway. L-tyrosine is converted into
L-DOPA by Tyrosine hydroxylase enzyme, while L-DOPA,
in turn, is transformed into DA through Dopa decarboxyl-
ase enzyme. Thus, the extra-ordinarily low concentration
of DA while normal concentrations of L-tyrosine and
L-DOPA would indicate the damage of Dopa decarboxylase
enzymes or its neuronal pathway. Such insights, thus, could
be an excellent indicator of the status of some neurodegen-
erative diseases. Therefore, the monitoring of DA as well as
the closest pre-derivatives of dopamine, such as L-tyrosine
and L-DOPA, would be the main focus of this study.
The detection of neurotransmitters has been performed
largely in four ways: electrochemical detection (ECD)
[10-17], fluorescence detection (FD) [18-21], chemilumin-
escence detection (CLD) [22-24], and mass spectrometric
detection (MSD) [25]. However, none of those approaches
have been successful in selectively detecting the co-existing
individual catecholamine neurotransmitters without using
additional separation techniques such as liquid chromato-
graphy or capillary electrophoresis that require complexOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Biosynthetic pathway of catecholamine neurotransmitters.
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Particularly, the ECD has been most frequently utilized for
the neurotransmitter detection due to its advantages of
high sensitivity, real time analysis, low cost, and easiness of
system miniaturization [17,26]; however, only the detection
of a single catecholamine neurotransmitter has been suc-
cessfully achieved because the conventional enzyme-based
electrochemical sensors, based on the redox reaction of cat-
echol groups with tyrosinase, was incapable of distinguish-
ing the neurotransmitters because each DA and L-DOPA
has identical catechol groups (two OH groups attached to
one benzene ring) that similarly react with the enzyme
attached to electrodes and generate redox reaction current.
To overcome such limitation we developed an electro-
chemical sensor using a differently-chemically-modified
microelectrode array with various CycloDextrin (CD)
‘catchers’ that are capable of engaging differently-sized
target molecules respectively due to physically unique
molecular structures. Note that previously it was known
that a CD could trap certain molecules better due to its
“basket”-type physical shapes, also known as the host-guest
recognition [12-14,27-30]; however, it has not been applied
for the selective identification of multiple catecholamine
neurotransmitters. Here we focus on the use of the CDs’
size differences to statistically produce unique affinities
to each of co-existing catecholamine neurotransmitters.
Especially, we employed three different α-, β-, and γ-CD
catchers, which have respectively six, seven, and eight
D-glucopyranose units based on their physically ‘matching’sizes (Figure 2), to identify three targets of L-tyrosine,
L-DOPA and DA.
Recently the use of cyclodextrins has been proven to
detect dopamine (DA) despite the interference of ascorbic
acid (AA) in a mixture [31-33]. Ascorbic acid has been
known to interfere the detection of dopamine due to the
overlap of the oxidation potentials and much higher (>100
times) concentrations. Based on these previous results, it
was reasonably hypothesized that the proposed approach
would properly function even in the presence of ascorbic
acids. Thus, in this paper we report the simultaneous and
quantitative detection approach to distinguish L-tyrosine,
L-DOPA and Dopamine in the absence of ascorbic acids as
the proof-of-concept. Particularly, we report the structure,
fabrication and characterization of a micro neurotransmit-
ter sensor as the proof-of-concept device, with particular
foci on detecting DA as well as its closest pre-derivatives.
The details will be reported of (1) microelectrode array fab-
rication, (2) electrode functionalization, (3) sensing sensitiv-
ity and selectivity and (4) simultaneous identification of the
mixture ratios among L-tyrosine, L-DOPA and Dopamine.Findings
Structure and operation principle
The developed micro neurotransmitter sensor consists of a
microelectrode array and an electrochemical chamber on a
silicon substrate (Figure 3-right bottom). The microelec-
trode array has four working electrodes (2 mm diameter) at
which electrochemical reaction takes place and one counter
electrode at the center among the four working electrodes.
Three of the four working electrodes are differently
and chemically functionalized by immobilizing α-, β-, and
γ-CDs respectively on its surface, while the fourth electrode
is not coated as a reference electrode. The counter elec-
trode works as a ground in potential measurement. The
electrochemical chamber contains the target solution with
neurotransmitters and exposes it to all five electrodes for
analysis. The total footprint of the sensor was 13 × 21 mm2.
The developed neurotransmitter sensor produces three
output signals through the host-guest recognition from each
of the three CD-coated electrodes, and the combination of
those three signals enables the identification of each concen-
tration of the co-existing three target neurotransmitters,
such as L-tyrosine, L-DOPA and dopamine. Since each
electrode is immobilized with different CDs with unique
size, shape, stereochemistry and surface charge, its surface
demonstrates variable affinities to each catecholamine
neurotransmitter. For example, the total output voltage,
measured at the α-CD electrode, is the combined results
from the respective responses to L-tyrosine, L-DOPA and
dopamine. Thus, each output signal at each electrode is the
combined contribution of each CD to all three target neuro-
transmitters. By combining such a relationship from all
Figure 2 Illustration of the sensing principle: differences in stereochemistry, surface charge and surface affinity of the three
catecholamine neurotransmitter derivatives cause different levels of host-guest recognition to α-, β- and γ-cyclodextrins, respectively,
enabling the sensing of individual derivative ratios from a mixture.
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lationship of the output signals can be expanded into three
equations:
A ¼ α1⋅LT þ α2⋅LDþ α3⋅DAþ α4
B ¼ β1⋅LT þ β2⋅LDþ β3⋅DAþ β4
C ¼ γ1⋅LT þ γ2⋅LDþ γ3⋅DAþ γ4
where A, B and C are the measured output signals at each
electrode with α-, β- and γ-cyclodextrins (CDs) coating,
respectively. α1, α2, and α3 are the response coefficients of
the α-CD electrode, while α4 are the sum of the offset
values to each target neurotransmitter. The same relation-
ship exists for β1, β2, β3, β4, γ1, γ2, γ3 and γ4. LT, LD and
DA indicate the concentrations of L-tyrosine, L-DOPA
and DA, respectively. Under the hypothesis that this
matrix is consistent (i.e. all the coefficients are independ-
ent), this set of three equations could be solved to deter-
mine the concentrations of LT, LD, and DA simultaneously,

























Note that in order to prove the selectivity of the method,
one exemplary ascorbic acid (vitamin C) was mixed into a
solution for in-vivo-like consideration while measuring the
three neurotransmitters.Fabrication
Micro electrode array fabrication
The microelectrode array was fabricated on a silicon
substrate (Figure 3-left). First, a SiO2 layer (200 nm) was
grown by wet oxidation, which served as an insulating layer.
Second, a TiW/Au layer (30 nm/600 nm) was sputtered on
top of the SiO2 layer, where the TiW layer enhanced the ad-
hesion between the Au and SiO2. Third, the deposited
metal layers were patterned using photolithography. KI and
diluted H2O2 solution were used as metal etchant and
Shipley 1813 positive photoresist as an etch mask. Finally,
the patterned substrate was cleaned by Acetone, IPA, and
DI water. The footprint of each electrode was 7.065 mm2.
Electrode functionalization
The fabricated microelectrode array was functionalized by
immobilizing CDs on its surface (Figure 3-right top). First,
the fabricated device was soft-baked on a hot plate at 80°C
for 10 min to remove residual water molecules on the
electrode surface because water molecules can prevent uni-
form coating of CDs molecules. Second, it was treated in a
1 mM cysteamine for 12 hr, which was prepared in ethanol,
for functionalizing amino-terminated monolayer. Third,
the modified electrode array was immersed in a 30 mM
of chlorobutyric acid (CA) for 2 hr, which was mixed
with 0.1 M N-hydroxysuccinimide (NHS) and 0.4 M ethyl
(dimethylaminopropyl) carbodiimide (EDC). This procedure
enabled to form amide binding between the chlorobutyric
acid and amino group, which changed the functionalized
Figure 3 Microfabrication flow and surface functionalization steps: the fabricated sensor contains three measuring electrodes,
respectively, coated with α-, β- and γ-cyclodextrins (CDs) and one reference electrode without coating.
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each mixture of 1 mM α-, β-, and γ-CDs and 20 ml of
aqueous 4 M KOH were selectively deposited on top of each
arrayed electrode at 65°C for 24 hr. The α-, β-, and γ-CDs
and all the chemicals that used for CD immobilization such
as Cysteamine (95%), CA, NHS, and EDC were purchased
from Sigma-Aldrich Co., USA.
Packaging
The functionalized microelectrode array was connected to
an electrochemical measurement system using copper wire.
The room temperature curable conductive paste (Silver
conductive adhesive paste, Alfa Aesar) was used to bond the
wire such that the immobilized CDs could avoid the thermal
damage from conventional solder bonding. While curing
the conductive paste, the microelectrode array was covered
with a water-absorbed filter paper (1002–185, Whatman)
to keep the CDs being sufficiently moisturized. After theconductive paste cured, an electrochemical chamber was
built on top of the fabricated sensor chip by bonding a
polycarbonate tube (inner diameter 10 mm, length 15 mm)
with epoxy (Quick Set™, Loctite).Methodology
Analysis of the functionalized electrode
The functionalized microelectrode array was analyzed
utilizing Fourier transform infrared spectrometry (FT-IR)
and X-ray photoelectron spectroscopy (XPS) to confirm the
immobilization of α-, β-, and γ-CDs. The FT-IR results
identify existence of chemical bindings after each step
of electrode functionalization over a wavelength range of
500-4000 nm (Perkin-Elmer Spectrum 100), while the XPS
measurements identify the existing atoms on the electrode
over electron beam power of 0-1000 eV (Kratos analytical
Axis Ultra DLD).
Figure 4 Surface analysis results of (top) FT-IR spectra and (bottom)
XPS measurement at each step of the electrode functionalization:
bare Au, cysteamine (thiol) coating, chlorobutyric acid (CA)
treatment, and α-cyclodextrins (CDs) immobilization. Signature
binding as well as key elements such as O 1 s, N 1 s, C 1 s and Cl 2p,
distinguishes the surface coating at each functionalization step.
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The fabricated neurotransmitter sensor was connected to a
potentiostat (Reference 600, Gamry Instruments) and test
data was monitored using a labview-based data recording
system (VFP600). The electrochemical cell was filled with
target catecholamine hormone solution, and the fabricated
sensor was tested in random mixtures of catecholamine
hormone targets (L-tyrosine, L-DOPA, and DA), concen-
trations (5 μM-10 mM), and scan rate (1-100 mV/s). First,
I-V curves of each electrode were measured in a specific
neurotransmitter concentration to measure the individual
responses of each CDs immobilized electrode. Next, by
varying the neurotransmitter concentrations between
5 μM-10 mM at every decade, the response curves were
constructed for each CD electrode and neurotransmitter.
The slope of the curve provides the sensitivity of each
electrode to each neurotransmitter. Then, from the col-
lected sensitivity coefficients, the matrix of quantification
was constructed to identify the individual concentrations
from a mixture. Finally, the individual concentrations were
extracted from random mixtures of L-tyrosine, L-DOPA
and dopamine and compared to the original values, in
order to validate the developed sensor and method.
Measurement was repeated at least five times, and all the




FT-IR spectra measurements at each stage of the surface
coating indicated that the CDs were successfully immo-
bilized on the Au surface of each electrode, as shown in
Figure 4-top. First, the characteristic peaks of -NH2 bend-
ing vibration and the symmetrical stretching vibration of
C-N appeared at 1545 cm−1 and at 1153 cm−1, respectively
after the first step of cystamine treatment on Au electrodes.
This indicates the formation of first amine functional layer
for the subsequent hydrogen bonding. Second, two new
peaks were measured at 1018 cm−1 and 1732 cm−1 after
the treatment of 4-chlorobutyric acid on the Au electrode.
These peaks correspond to the C-O-C stretching vibration
and amide binding between amine and carboxylic group,
respectively, indicating that the outermost coating now be-
comes chlorobutyric acid available for CD immobilization.
Finally, the additional new peaks were also observed at
847 cm−1 (C-H deformation in α-pyranose compounds)
and 953 cm−1 (asymmetric pyranose ring stretch). These
peaks are conventional signatures for typical CDs, eviden-
cing that CDs had been immobilized on the Au surface as
the outmost chemical acceptor.
XPS survey scan measurements, complementing the
FT-IR spectra results, indicated that the key elements,
such as nitrogen and chlorine, appeared and disappeared
as the surface coating progresses. Figure 4-bottom displaysthe baseline binding energy of each element at the bare
Au surface. In comparison, the peak of nitrogen (N 1 s)
was observed at the binding energy of 397.1 eV after
cysteamine treatment that creates amino termination. The
peak for carbon (C 1 s) was also measured throughout the
coating steps at the binding energy of 281.6 eV. Then, an
additional peak of chlorine (Cl 2p) was measured at the
binding energy at 192.6 eV, after chlorobutyric acid
treatment that forms chlorine termination. Note that the
oxygen (O 1 s) spectrum was observed as a distinctive
peak at 529.4 eV, indicating the increased hydrophilicity
on the functionalized Au surface. This enables the surface
to easily interact with water molecules thus efficiently
capture CDs. The peak of chlorine was not measured once
the cholorobutyric acid replaced chlorine element with
α-CDs. This confirms the existence of the α-CDs on the
Au electrode.
Figure 5 Cyclic voltammograms of each electrode with the α-, β-,
and γ-CDs immobilization, respectively, under the 1 mM solutions
of (top) L-tyrosine, (Middle) L-dopa and (bottom) dopamine. The
scan rate was 100 mV/s. The current amounts at the given concentration
(1 mM) were identified to produce the quantification matrix at each
oxidation potential point that was measured without CD immobilization.
The footprint of each electrode was 7.065 mm2.
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a mixture
Cyclic voltammetry measurements demonstrated that
each electrode responses to respective neurotransmitter
with different order of preferences and degrees (Figure 5).
The γ-electrode produced the highest output under the
same concentration of L-tyrosine, while the β-electrode
showed the maximum signal outputs from both L-DOPA
and dopamine. Although the α-electrode did not demon-
strate the highest output to any of the neurotransmitters,
it responded the second highest output to L-tyrosine and
dopamine. Figure 5 shows the cyclic voltammograms re-
spectively obtained from 1 mM of L-tyrosine, L-DOPA
and DA in PBS from each electrode with the footprint of
7.065 mm2, resulting in different output responses under
the same neurotransmitter. In response to 1 mM of
L-tyrosine at the L-tyrosine oxidation potential, the
γ-electrode produced the highest output current of
1.765 μA and then the β- and α-electrodes produced
1.176 and 0.515 μA, respectively (Figure 5-top). This
corresponds to the current densities of 0.250, 0.167 and
0.073 μA/mm2. The electrodes with chlorobutyric acid or
cysteamine coating without cyclodextrins did not produce
measurable output currents. The oxidation potential of
each neurotransmitter was separately obtained utilizing
conventional platinum electrodes. In response to L-
DOPA, the generated output signals ranged at 12.123,
7.397 and 6.37 μA with coatings of β-, γ-, α-cyclodextrins,
chlorobutyric acid and cystemine (Figure 5-Middle),
with corresponding current densities of 1.716, 1.047 and
0.902 μA/mm2, respectively. In the 1 mM dopamine solu-
tion, the β-, α- and γ-electrodes produced current outputs
of 11.811, 9.213 and 7.323 μA and densities of 1.672, 1.304
and 1.037 μA/mm2, respectively (Figure 5-bottom). These
results indicate that each cyclodextrins, thus each
electrode, holds different affinity in catecholamine hor-
mones. Note that the minimum detectable amount was
5 μM, limited by the resolution of measurement. Also
note that the testing was performed up to 10 mM of
concentrations to fully cover the maximum range feasible
in-vivo environment. Thus, the overall concentration
ranges tested were limited between 5 μM and 10 mM in
this paper.
Amperometric measurement results demonstrated that
the output current produced from each electrode with
α-, β-, and γ-immobilization increased linearly with
increasing concentrations between 0.005 and 10 mM in
logarithmic scale (Figure 6). The linear relationship
between each electrode and neurotransmitter produced
substantially different slopes, which confirms selective
discrimination of each electrode by the terminated CDs.
In response to L-tyrosine, α-, β- and γ-electrodes respect-
ively exhibited linear slopes of 0.2035, 0.1055 and 0.2897,
which forms a multiplication factor matrix as:
Figure 6 Amperometric responses of each electrode with the α-, β-, and γ-CDs immobilization, respectively, under various
concentrations between 10−2 and 101 mM at each solution of L-tyrosine, L-dopa and dopamine. The output current amounts were
measured as to have linear relationships under logarithmic concentration ranges. The slope and offset data for each curve are extracted to form a
matrix of quantification. The footprint of each electrode was 7.065 mm2.
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By expanding the matrix to L-DOPA and dopamine,






























where I(α), I(β) and I(γ) are the output currents at each
electrode and LT, LD and DA represent the concentrations
in mM. This matrix enables the detection of individual
amounts of each neurotransmitters from a mixture.Random mixture measurement results, without vitamin
C (an ascorbic acid), demonstrated that individual concen-
trations of L-tyrosine, L-DOPA and dopamine can be
identified utilizing the CD-based electrode as listed in
Table 1. A total of three different mixture cases was evalu-
ated at least five repeated experiments without ascorbic
acids as explained earlier. The Mixture 1 included minute
amounts of 0.035, 0.010 and 0.005 mM; the mixture 2
contained 0.39, 1.11, and 0.68 mM; and the Mixture 3
consisted of 1.10, 3.24 and 2.37 mM, respectively of
L-tyrosine, L-DOPA and dopamine. Each mixture without
ascorbic acids produced the output currents of 10.531,
8.921, and 11.531 μA; 18.722, 18.724 and 18.758 μA; and
20.73, 21.11, and 20.56 μA respectively from α-, β- and
γ-electrodes. By supplying the output currents into
the constructed matrix of quantification, the supplied
concentrations were estimated as 0.035, 0.010 and
Table 1 Experimental measurement-based quantification results of three neurotransmitter mixture cases with and
without ascorbic acid (1 mM of vitamin C): (Case I) 0.035, 0.010 and 0.005 mM; (Case II) 0.39, 1.11, and 0.68 mM; and
(Case III) 1.10, 3.24, and 2.37 mM of L-tyrosine, L-dopa and dopamine, respectively
Mixture I
Input (No ascorbic acid) Output Accuracy output/input (error)
Measurement Estimated from measurement
Type mM Electrode μA Type mM
L-tyrosine 0.035 α-CD 10.531 L-tyrosine 0.0372 106.30% (+6.30%)
L-dopa 0.010 β-CD 8.921 L-dopa 0.0093 92.83% (−7.17%)
Dopamine 0.005 γ-CD 11.531 Dopamine 0.0052 105.05% (+5.05%)
Mixture II
Input (No ascorbic acid) Output Accuracy output/input (error)
Measurement Estimated from measurement
Type mM Electrode μA Type mM
L-tyrosine 0.39 α-CD 18.722 L-tyrosine 0.3915 100.37% (+0.37%)
L-dopa 1.11 β-CD 18.724 L-dopa 1.1045 99.51% (−0.49%)
Dopamine 0.68 γ-CD 18.758 Dopamine 0.6678 98.19% (−1.81%)
Mixture III
Input (No ascorbic acid) Output Accuracy output/input (error)
Measurement Estimated from measurement
Type mM Electrode μA Type mM
L-tyrosine 1.10 α-CD 20.73 L-tyrosine 1.1690 106.28% (+6.27%)
L-dopa 3.24 β-CD 21.11 L-dopa 3.3399 103.08% (+3.08%)
Dopamine 2.37 γ-CD 20.56 Dopamine 2.2724 95.88% (−4.12%)
Experimental data indicated above are the average of at least five experiments. The testing was performed within 10 minutes of fabrication.
Figure 7 Composition identification accuracy over time utilizing α-, β-, and γ-electrodes under 100uM ascorbic acid (vitamin C). Error
bars indicate the deviation over five experiments. The results indicate that the neurotransmitter sensor provides stable outputs up to 6 hours.
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2.37 mM respectively for the Mixtures 1, 2 and 3. These
estimated results ranged within 92.41% and 106.30% of
the supplied values for Mixtures 1, 2 and 3, verifying the
concept of CD-based quantitative identification of mixed
neurotransmitters. Note that all the Mixtures were evalu-
ated within 6 hours of the device fabrication to minimize
the performance drift over time.
The measurement results indicated that the average ac-
curacy of the neurotransmitter sensor degraded over time
from 93.2 (used immediately after fabrication) and 93.4
(within 6 hours) to 85.2, 81.4, 75.2 and 74.9%, respectively
for within 12, 24, 36 and 48 hours (Figure 7). The meas-
urement also showed that the deviations of the accuracy
increased over time from 2.1 to 18.2%, indicating the reli-
able measurement periods after fabrication up to 6 hours.
Conclusion
A new neurotransmitter sensing technique has been
examined to enables quantitative detection of three major
catecholamine hormones from a mixture. Specifically, the
sensing technique utilized three chemically-modified mi-
croelectrodes, respectively, with α-, β- and γ-cyclodextrin
(CD) ‘catchers’. The sensing technique relied on different
physical matching (size and shape) as well as chemical
enticing (stereochemistry and surface charge) properties
of α-, β-, and γ-CDs in order to produce statistically differ-
ent affinities to each target catecholamine neurotransmit-
ters of L-tyrosine, dihydroxyphenylalanine (L-DOPA) and
dopamine. The developed neurotransmitter sensing tech-
nique has successfully identified three individual catechol-
amine hormones, without the existence of ascorbic acid,
with respective CD ‘catchers’: α-CDs better responded to
L-tyrosine and dopamine; β-CDs to L-DOPA and dopa-
mine; and γ-CDs to L-tyrosine, respectively. It also dem-
onstrated the linear sensitivities to each neurotransmitter
with logarithmically increasing concentrations range of
5 μM-10 mM. The measurement accuracy changed over
time, indicating the stability up to 6 hours from the fabri-
cation. The demonstrated accuracy, over >5 tests near
1 mM of target concentrations, was within 91.2%, and the
total device footprint was 13 × 21 mm2.
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